Retuning the body

Retuning the body

About Cala Health

Cala Health is a medical technology company pioneering a new class of electrical medicine called neuroperipheral therapy. Neuroperipheral therapy has the potential to address chronic disease by externally stimulating peripheral nerves with body-worn electronics. Cala Health is bringing together experts in neuroscience, consumer electronics, and medical devices to develop accessible therapies that treat chronic disease non-invasively.


Cala Health Enrolls First Patients in Landmark PROSPECT Study for Essential Tremor

December 17, 2018

Cala Health Receives FDA Clearance for Cala ONE, A Neuroperipheral Therapy for Essential Tremor

April 26, 2018

American Academy of Neurology 2018 Emerging Science Program: Non-Invasive Peripheral Nerve Stimulation for Symptomatic Relief of Hand Tremor in Essential Tremor

April 19, 2018

Noninvasive Neuromodulation in Essential Tremor Demonstrates Relief in a Sham-Controlled Pilot Trial

April 17, 2018

Exponential Medicine 2017: Delivering Electricity as Medicine

November 8, 2017

Cala Health's CEO Kate Rosenbluth selected as a Hive Innovator for 2017 by TEDMED

November 2, 2017

Therapeutic Pipeline Highlight: Essential Tremor

Essential Tremor (ET) is a common movement disorder affecting over 7 million Americans and millions more worldwide. The condition is marked by hand tremors that make it difficult, if not impossible, to perform daily activities like eating, drinking, and writing. Cala Health is working on a solution that retunes the nervous system in order to relieve the symptoms of ET. Cala Health is striving to put patients in control of their tremor — without the need for invasive brain surgery or drugs. Cala Health supports the International Essential Tremor Foundation (IETF) and works to connect people living with essential tremor to new therapies. For more information about essential tremor, visit

Our Team

Executive Team

Kate Rosenbluth, PhD
Kate Rosenbluth, PhD CEO

Kate Rosenbluth co-founded Cala Health with Scott Delp PhD and Serena Wong PhD. She has developed cutting-edge neurotherapies with Brainlab, Autonomic Technologies, and Genentech. She was a lecturer and fellow in Stanford Technology Ventures Program and Biodesign and a Postdoctoral Fellow in UCSF Neurosurgery. Kate has authored more than 50 patents and peer-reviewed publications.

Kristie Burns
Kristie Burns Chief Marketing Officer

Kristie Burns has held strategic marketing leadership and business development roles with medical device and biotechnology leaders, ResMed and Advanced Tissue Sciences. She brings 20+ years of market development and digital health experience to Cala Health. Kristie started her career with 5 years in health care consulting with LBA/HCIA.

Scott Wilson, PhD
Scott Wilson, PhD VP of Quality Assurance and Regulatory Affairs

Scott Wilson has 25 years of quality and regulatory accomplishments helping medical device companies achieve critical market-development milestones including IDE, PMA, CE Mark, and other approvals. Scott was part of the regulatory teams at Allergan and Edwards Lifesciences, and a member of executive leadership for Radiant Medical, Ardian (MDT), Kona Medical, and Twelve (MDT).

John Colombo
John Colombo VP of Product Development and Operations

John Colombo has 20+ years of experience in New Product Development and Operations, focusing on consumer electronics operations most recently. He was the operations lead for the Apple iPod HiFi and was a key team member on the Palm Pre and Pixi. John is experienced in global logistics, direct fulfillment and gained medical device operations experience at ExploraMed.

Manish Gupta
Manish Gupta VP of Clinical Affairs

Manish Gupta has over 15 years of experience in developing and executing clinical trials to gain product approvals (PMA, 510(k), CE mark) and market acceptance in global cardiac and neurological device markets. He has held clinical affairs and medical affairs strategic leadership roles at Medtronic, Covidien, and St. Jude Medical (Abbott Labs). Under Manish’s leadership, clinical evidence generation also led to changes in AHA & ESOC guidelines.

Chris Daniel
Chris Daniel VP, Commercial Operations

Chris Daniel has over 25 years of medical device experience with more than 12 years in executive leadership. He’s worked in startups leading development, operations, quality, regulatory, finance, and commercial discovery & operations for twelve years. Companies include Stryker, HeartPort, Rubicor, and ApniCure. He’s a co-inventor on over three dozen issued and pending patents.


Join the Team

We are a team of innovators with a passion for enabling healthy and joyful living. We are creating breakthrough treatments by bringing together exceptional people at the intersection of engineering, neuroscience, and medicine.

We are growing the team with people who share a:

PASSION FOR USER-FOCUSED DESIGN that engages the community of patients, physicians, healthcare providers, caregivers, and loved ones.

COMMITMENT TO SCIENCE that drives the discovery and validation of innovative healthcare solutions.

RELENTLESS CURIOSITY to translate innovative healthcare solutions across the fields of personalized medicine, neuroscience, hardware and software.


Stay In Touch With Cala Health

I am interested in Cala Health for






Thank You For Contacting Cala Health

Thank you for getting in touch! We appreciate you contacting us. Our team will send you an introductory email very soon.


For more information about our company and our clinical studies email us at:

We are located at:

Cala Health

875 Mahler Rd #168 Burlingame, CA 94010

Phone: (415) 890-3961